Emami Limited (BOM:531162)
403.15
-5.00 (-1.23%)
At close: Aug 21, 2026
Emami Revenue
Emami had revenue of 10.39B INR in the quarter ending June 30, 2026, with 14.95% growth. This brings the company's revenue in the last twelve months to 39.15B, up 2.82% year-over-year. In the fiscal year ending March 31, 2026, Emami had annual revenue of 37.80B, down -0.78%.
Revenue (ttm)
39.15B
Revenue Growth
+2.82%
P/S Ratio
4.50
Revenue / Employee
12.64M
Employees
3,097
Market Cap
175.97B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 37.80B | -296.75M | -0.78% |
| Mar 31, 2025 | 38.09B | 2.31B | 6.46% |
| Mar 31, 2024 | 35.78B | 1.72B | 5.06% |
| Mar 31, 2023 | 34.06B | 2.19B | 6.86% |
| Mar 31, 2022 | 31.87B | 3.07B | 10.65% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bajaj Consumer Care | 12.33B |
| Anondita Medicare | 1.37B |
| Recode Studios | 799.50M |
| MFL India | 626.65M |
| Aakaar Medical Technologies | 592.04M |
| Ravelcare | 269.54M |
| Paramount Cosmetics (India) | 200.80M |
| Novateor Research Laboratories | 38.27M |
Emami News
- 18 days ago - Emami Transcript: Q1 26/27 - Transcripts
- 18 days ago - Emami Quarterly report: Q1 2027 - Filings
- 18 days ago - Emami Slides: Q1 2027 - Filings
- 3 months ago - Emami Transcript: Q4 25/26 - Transcripts
- 3 months ago - Emami Quarterly report: Q4 2026 - Filings
- 3 months ago - Emami Slides: Q4 2026 - Filings
- 3 months ago - Emami Annual report: Q4 2026 - Filings
- 3 months ago - Emami missed its 10% revenue growth target by the widest margin in years — what went wrong in FY26 - Business Upturn